Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Becker

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Arthritis Care & Research|November 5, 2011
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinolSaima Chohan, Michael A Becker, Patricia A MacDonald, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
In memoriam: J. Edwin Seegmiller, M.D. (1920-2006)Michael A Becker, Theodore Friedmann, Kari O Raivio, et al.
The Journal of Rheumatology|March 17, 2009
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with goutMichael A Becker, H Ralph Schumacher, Patricia A MacDonald, et al.
ACS Nano|August 3, 2022
Robust Tipless Positioning Device for Near-Field Investigations: Press and Roll Scan (PROscan)Hsuan-Wei Liu, Michael A Becker, Korenobu Matsuzaki, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapyMichael A Becker, Patricia A MacDonald, Barbara J Hunt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2016
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal ImpairmentKenneth G Saag, Andrew Whelton, Michael A Becker, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 25, 2014
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapyHerbert S B Baraf, Robert A Yood, Faith D Ottery, et al.
Arthritis and Rheumatism|July 9, 2003
Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young womanPablo García-Pavía, Rosa J Torres, Manuel Rivero, et al.
Life Sciences|February 9, 2005
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenaseYasuhiro Takano, Kumiko Hase-Aoki, Hideki Horiuchi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2018
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled StudyKenneth G Saag, Michael A Becker, Andrew Whelton, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Arthritis Care & Research|November 5, 2011
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinolSaima Chohan, Michael A Becker, Patricia A MacDonald, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
In memoriam: J. Edwin Seegmiller, M.D. (1920-2006)Michael A Becker, Theodore Friedmann, Kari O Raivio, et al.
The Journal of Rheumatology|March 17, 2009
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with goutMichael A Becker, H Ralph Schumacher, Patricia A MacDonald, et al.
ACS Nano|August 3, 2022
Robust Tipless Positioning Device for Near-Field Investigations: Press and Roll Scan (PROscan)Hsuan-Wei Liu, Michael A Becker, Korenobu Matsuzaki, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapyMichael A Becker, Patricia A MacDonald, Barbara J Hunt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2016
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal ImpairmentKenneth G Saag, Andrew Whelton, Michael A Becker, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 25, 2014
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapyHerbert S B Baraf, Robert A Yood, Faith D Ottery, et al.
Arthritis and Rheumatism|July 9, 2003
Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young womanPablo García-Pavía, Rosa J Torres, Manuel Rivero, et al.
Life Sciences|February 9, 2005
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenaseYasuhiro Takano, Kumiko Hase-Aoki, Hideki Horiuchi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2018
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled StudyKenneth G Saag, Michael A Becker, Andrew Whelton, et al.
Pageof 6